Click here to close now.


News Feed Item

Plandai Biotechnology Management Discusses Progress of Company's Cannabis Extracts

NEW YORK, NY -- (Marketwired) -- 03/28/14 -- Last month Plandaí Biotechnology, Inc. (OTCQB: PLPL) closed a licensing agreement with Diego Pellicer, Inc. that will allow the company to use the Diego Pellicer name for its Phytofare™ cannabis extract in medical and pharmaceutical marijuana applications. Plandaí will produce the new Diego Pellicer Gold™ extracts in both capsules and cannabis oil (for vapor use) in Pheroid™ and non-Pheroid™ versions to appeal to the broadest range of medicinal consumers.

Stock Market Media Group (SMMG), a full service research and content development investor relations firm, asked Plandaí's management about the company's journey to introduce cannabis extracts to the market.

SMMG: Where is Plandai in the process of adding cannabis products?

Plandaí: "We are doing several things simultaneously. First, we're reviewing the various strains of cannabis and selecting one that we feel will have the best chemical profile for what we want to accomplish with the extract.

We're also working in Washington to ensure that we have live plant matter available for testing later in the year. Finally, we are engineering a CRS hydrodynamic processing and extraction system and constructing a laboratory in Washington that will make the initial extract for testing."

SMMG: What has been completed in the process and what is left to complete?

Plandaí: "The initial steps involved determining if we could even make a cannabis extract. This involved a review of the legal environment, the physical properties of the plant, and the chemical properties of the plant. We then needed to hire a small team that could 1) Select the correct strain, 2) Establish cultivation protocols, 3) Reach out to investigational institutions to begin lining up clinical trials, and 4) Adapt our current extraction system to be able to process cannabis. All of these things have happened.

We expect to finalize terms with a cultivation facility in the coming weeks so that we have suitable established plants in adequate quantities by this fall to begin making sample extract. Remember, we must use live plant material and we must use a specific and reproducible strain. We can't just go into a shop and buy dry leaf. Working with local growers, we need to document their cultivation techniques, fertilizer, etc. All of these things can impact the chemical profile. So, we need to manage the process to ensure that we have the correct chemical profile.

Concurrently, we will be building a small-scale lab so that we can produce our first cannabinoid extract. This will then need to be tested to get a chemical profile. We then need to test it for bioavailability and establish dosage parameters. Only then can we start testing for specific medical properties and benefits."

SMMG: What role will both the hydrodynamic sheering process and Pheroid® play in the production of extracts?

Plandaí: "The hydrodynamic sheering process is what breaks down and separates the plant structures, giving us increased bioavailability as well as allowing us to maximize the amount of phytonutrients we extract. All of our products will go through this process. The specific processing challenges we face with cannabis are releasing THC and CBD from the viscous cannabis oil and in the process reducing the articles to a high percentage of nano from the current ratio of 250-350mg. To achieve this, new formulated liquids will be used in the processing cycle.

The Pheroid® brings in certain additional properties which, depending on the individual may be considered advantageous or disadvantageous.

Essentially, the Pheroid® will entrap the cannabinoids until they reach the cells. This means that the THC will not metabolize in the blood stream, thus conceivably eliminating the psychoactive effects. We believe that we will be able to deliver a meaningful dosage of cannabinoids without the accompanying 'high.'

This will be ideal for patients with neural disorders and diseases. Some conditions require or prefer the metabolized THC and welcome the associated psychoactive effects. Thus, we expect to develop and test both a Pheroid® and non-Pheroid® version of the product."

SMMG: Where will these extracts be sold?

Plandaí: "We do not plan on having retail locations or selling directly to consumers. We are an ingredient manufacturer for nutraceutical and pharmaceutical applications. We will produce our extracts and then look to sell them to manufacturers of finished goods or into medicinal applications."

SMMG: What role, if any, will your South African plantation and manufacturing facility play in the future of your cannabis extract?

Plandaí: "Presently, South African law prohibits the cultivation of cannabis and furthermore it would be impossible to legally export or import any cannabis-based products or extracts. Our South Africa estate and factory is set up exclusively for processing our Phytofare™ Catechin Complex, which is made from green tea, though eventually we expect to also produce a citrus complex at this same facility. So, our South Africa operations will not be involved in any way for the foreseeable future. Until we are through with our research and animal trials, it is premature to speculate on when, if, or where we will produce a commercial cannabis extract, but we will only be involved if we can be assured that we are complying with all Federal and state laws.

As we recently announced, however, an appeal was made on our behalf to the South African legislature to grant Plandaí a special dispensation, or waiver, allowing us to produce and test a cannabinoid Phytofare™ extract for human clinical trials. In addition, legislation has recently been introduced in South Africa to permit medical marijuana research. Should this legislation pass, or should the government grant us special dispensation, it could open up the door to advancing medical research on an accelerated basis. We will know more in the coming months and will keep our shareholders apprised of any developments on this front."

About Stock Market Media Group

SMMG is a full service IR firm specializing in Research and Content Development. It offers a platform for corporate stories to unfold through the media with Reports, Interviews and Articles. SMMG is compensated for Plandaí articles, reports and interviews by a third party who reserves the right to sell securities at any time before, during, or after the publication of this article. To date, SMMG has received total compensation of $36,290, for content related to Plandaí. For more information and to read full disclaimers and disclosures:

Add to Digg Bookmark with Add to Newsvine

Stock Market Media Group
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
SYS-CON Events announced today that Harbinger Systems will exhibit at SYS-CON's 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Harbinger Systems is a global company providing software technology services. Since 1990, Harbinger has developed a strong customer base worldwide. Its customers include software product companies ranging from hi-tech start-ups in Silicon Valley to leading product companies in the US a...
Overgrown applications have given way to modular applications, driven by the need to break larger problems into smaller problems. Similarly large monolithic development processes have been forced to be broken into smaller agile development cycles. Looking at trends in software development, microservices architectures meet the same demands. Additional benefits of microservices architectures are compartmentalization and a limited impact of service failure versus a complete software malfunction....
The last decade was about virtual machines, but the next one is about containers. Containers enable a service to run on any host at any time. Traditional tools are starting to show cracks because they were not designed for this level of application portability. Now is the time to look at new ways to deploy and manage applications at scale. In his session at @DevOpsSummit, Brian “Redbeard” Harrington, a principal architect at CoreOS, will examine how CoreOS helps teams run in production. Attende...
Containers are revolutionizing the way we deploy and maintain our infrastructures, but monitoring and troubleshooting in a containerized environment can still be painful and impractical. Understanding even basic resource usage is difficult - let alone tracking network connections or malicious activity. In his session at DevOps Summit, Gianluca Borello, Sr. Software Engineer at Sysdig, will cover the current state of the art for container monitoring and visibility, including pros / cons and li...
The Internet of Things (IoT) is growing rapidly by extending current technologies, products and networks. By 2020, Cisco estimates there will be 50 billion connected devices. Gartner has forecast revenues of over $300 billion, just to IoT suppliers. Now is the time to figure out how you’ll make money – not just create innovative products. With hundreds of new products and companies jumping into the IoT fray every month, there’s no shortage of innovation. Despite this, McKinsey/VisionMobile data...
Today’s connected world is moving from devices towards things, what this means is that by using increasingly low cost sensors embedded in devices we can create many new use cases. These span across use cases in cities, vehicles, home, offices, factories, retail environments, worksites, health, logistics, and health. These use cases rely on ubiquitous connectivity and generate massive amounts of data at scale. These technologies enable new business opportunities, ways to optimize and automate, al...
In their session at DevOps Summit, Asaf Yigal, co-founder and the VP of Product at, and Tomer Levy, co-founder and CEO of, will explore the entire process that they have undergone – through research, benchmarking, implementation, optimization, and customer success – in developing a processing engine that can handle petabytes of data. They will also discuss the requirements of such an engine in terms of scalability, resilience, security, and availability along with how the archi...
Redis is not only the fastest database, but it has become the most popular among the new wave of applications running in containers. Redis speeds up just about every data interaction between your users or operational systems. In his session at 17th Cloud Expo, Dave Nielsen, Developer Relations at Redis Labs, will share the functions and data structures used to solve everyday use cases that are driving Redis' popularity
In his session at DevOps Summit, Bryan Cantrill, CTO at Joyent, will demonstrate a third path: containers on multi-tenant bare metal that maximizes performance, security, and networking connectivity.
The buzz continues for cloud, data analytics and the Internet of Things (IoT) and their collective impact across all industries. But a new conversation is emerging - how do companies use industry disruption and technology enablers to lead in markets undergoing change, uncertainty and ambiguity? Organizations of all sizes need to evolve and transform, often under massive pressure, as industry lines blur and merge and traditional business models are assaulted and turned upside down. In this new da...
Any Ops team trying to support a company in today’s cloud-connected world knows that a new way of thinking is required – one just as dramatic than the shift from Ops to DevOps. The diversity of modern operations requires teams to focus their impact on breadth vs. depth. In his session at DevOps Summit, Adam Serediuk, Director of Operations at xMatters, Inc., will discuss the strategic requirements of evolving from Ops to DevOps, and why modern Operations has begun leveraging the “NoOps” approa...
Docker is hot. However, as Docker container use spreads into more mature production pipelines, there can be issues about control of Docker images to ensure they are production-ready. Is a promotion-based model appropriate to control and track the flow of Docker images from development to production? In his session at DevOps Summit, Fred Simon, Co-founder and Chief Architect of JFrog, will demonstrate how to implement a promotion model for Docker images using a binary repository, and then show h...
Too often with compelling new technologies market participants become overly enamored with that attractiveness of the technology and neglect underlying business drivers. This tendency, what some call the “newest shiny object syndrome,” is understandable given that virtually all of us are heavily engaged in technology. But it is also mistaken. Without concrete business cases driving its deployment, IoT, like many other technologies before it, will fade into obscurity.
Today air travel is a minefield of delays, hassles and customer disappointment. Airlines struggle to revitalize the experience. GE and M2Mi will demonstrate practical examples of how IoT solutions are helping airlines bring back personalization, reduce trip time and improve reliability. In their session at @ThingsExpo, Shyam Varan Nath, Principal Architect with GE, and Dr. Sarah Cooper, M2Mi's VP Business Development and Engineering, will explore the IoT cloud-based platform technologies driv...
SYS-CON Events announced today that Sandy Carter, IBM General Manager Cloud Ecosystem and Developers, and a Social Business Evangelist, will keynote at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA.